Cardiac Safety Analysis of Anti–HER2-Targeted Therapy in Early Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Scientific Reports
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cardiac safety analysis of anti-HER2-targeted therapy in early breast cancer
Sci Rep 2022 Aug 22;12(1)14312, L Zhang, Y Wang, W Meng, W Zhao, Z TongFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.